AN AREA of Scotland has been revealed as a world hotspot for Huntington’s disease. New research has revealed the shockingly ...

Factors driving the market include rising disease prevalence, innovative therapies, and gene-based treatment breakthroughs. Key players like H Lundbeck and Pfizer are fueling research and development ...

Shawn Kortes, known for his philanthropic work in the community, started dialysis this year and is searching for a kidney ...

An "unprecedented" toxic algae bloom has overrun the coast of Southern California, sickening marine animals and staining the ...

and quality of life in patients with early-stage ALS. uniQure says it has reached agreement with the FDA on a pathway to accelerated approval for its much-anticipated Huntington's disease gene ...

What's been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

Presymptomatic testing for Huntington disease (HD) has been available for ... had experienced discrimination with regard to life insurance or long-term disability insurance, or from mortgage ...

Diagnosis of neurodegenerative disease is currently often made too late in the disease progression for effective treatment to ...

Dutch gene therapy company uniQure (Nasdaq: QURE) announced that the US Food and Drug Administration (FDA) has granted ...

Roche has stopped dosing in a phase 3 trial of tominersen, a potential Huntington’s disease (HD ... The ESG in Life Sciences Summit West is coming to San Francisco! (July 8-10, 2025).

Symptoms of young-onset dementia have considerable overlap with those common in certain mental health conditions, such as bipolar disorder, psychosis, depression and anxiety. Symptoms might also ...